KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Interest Expenses (2016 - 2025)

Evolent Health has reported Interest Expenses over the past 10 years, most recently at $19.0 million for Q4 2025.

  • Quarterly results put Interest Expenses at $19.0 million for Q4 2025, up 182.89% from a year ago — trailing twelve months through Dec 2025 was $57.5 million (up 132.47% YoY), and the annual figure for FY2025 was $57.5 million, up 132.47%.
  • Interest Expenses for Q4 2025 was $19.0 million at Evolent Health, up from $16.5 million in the prior quarter.
  • Over the last five years, Interest Expenses for EVH hit a ceiling of $19.0 million in Q4 2025 and a floor of $2.1 million in Q2 2022.
  • Median Interest Expenses over the past 5 years was $6.4 million (2021), compared with a mean of $8.9 million.
  • Biggest five-year swings in Interest Expenses: tumbled 65.76% in 2022 and later surged 573.09% in 2023.
  • Evolent Health's Interest Expenses stood at $6.4 million in 2021, then decreased by 0.28% to $6.4 million in 2022, then skyrocketed by 90.36% to $12.2 million in 2023, then crashed by 45.09% to $6.7 million in 2024, then skyrocketed by 182.89% to $19.0 million in 2025.
  • The last three reported values for Interest Expenses were $19.0 million (Q4 2025), $16.5 million (Q3 2025), and $11.6 million (Q2 2025) per Business Quant data.